Intelligence · Clinical pipeline
Infectious disease R&D Pipeline
Antiviral, antibacterial, and infectious disease vaccine pipeline programs.
Quick answer
Infectious disease: NovaPharmaNews indexes 1,112 infectious disease clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Antiviral, antibacterial, and infectious disease vaccine pipeline programs.
Top sponsors
- United Therapeutics Europe 94 programs
- BRIGHT MINDS BIOSCIENCES 81 programs
- Chinese Academy of 77 programs
- Sinovac Research and 49 programs
- GSK Glaxo Smith 39 programs
- Takeda 33 programs
- First People's Hospital 31 programs
- Vertex Pharmaceuticals (Australia) 30 programs
- Vir Biotechnology 26 programs
- George Institute for 25 programs
- ENANTA PHARMACEUTICALS 22 programs
- Hospital Authority 22 programs
Pipeline programs
-
BAL2420-CP-101
Lacuna Pharma Pty Ltd
Severe infections caused by Gram-negative bacteria
1 trial -
BCX4430
Biocryst
Filovirus Infections
1 trial -
BGB DXP593
BeiGene
Covid19
1 trial -
BNT351-01
BioNTech SE
HIV-1 infection
1 trial -
BS-02
Blue Earth Diagnostics Ireland Ltd
Treatment of human papilloma virus (HPV) associated infections, precancers and cancers
1 trial -
BS-03
Blue Earth Diagnostics Ireland Ltd
Treatment of human papilloma virus (HPV) associated infections and cancers
1 trial -
Bempegaldesleukin
Nektar Therapeutics UK Limited
Covid-19
1 trial -
CD19/CD20 Dual-Target in vivo CAR-T Lentiviral product
Nanjing Legend Biotech Co.
Relapsed/Refractory B-cell Malignancies
1 trial -
CINE963A02103
Novartis Pharmaceuticals
Malaria
1 trial -
CLARI-21-24
Lacuna Pharma Pty Ltd
Infectious diseases
1 trial -
CLBS119
LISATA THERAPEUTICS, INC.
Covid-19
1 trial -
CM-101
Chemomab Therapeutics
Nonalcoholic Steatohepatitis (NASH)
1 trial -
CMV-TCR-T cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
CMV Infection or Reactivation After Allogenic HSCT
1 trial -
COVID-HIG
United Therapeutics Europe Ltd
SARS-CoV-2 Infection
1 trial -
COVID-HIGIV
United Therapeutics Europe Ltd
COVID-19
1 trial -
CPA 556-24
s.r.o.
healthy subjects, It is used in conditions with decreased immunity to enhance it e.g. in case of recurrent and chronic viral infections.
1 trial -
CPI-006
Corvus Pharmaceuticals
COVID-19
1 trial -
CRV431
Hepion Pharmaceuticals
Hepatitis B
1 trial -
CSL760
CSL Behring GmbH
Coronavirus Disease 2019 (COVID-19)
1 trial -
CTX-187-101
Centauri Biotech SL
Bacterial Infection
1 trial -
CX842B2111
Lacuna Pharma Pty Ltd
Helicobacter pylori infection, GERD
1 trial -
Campylobacter jejuni strain CG8421
United Therapeutics Europe Ltd
Campylobacter Infections
1 trial -
Casirivimab and Imdevimab Antibody Cocktail
Regeneron UK Limited
COVID-19
1 trial -
Ceftobiprole OATP1B interaction study
Lacuna Pharma Pty Ltd
Community-acquired bacterial pneumonia
1 trial -
Chloroquine
GlaxoSmithKline
Malaria
1 trial -
Coadministration of GA2 Sporozoites With Adjuvants (CoGA)
Disc Medicine
Falciparum malaria
1 trial -
D/ChAd63-CA
United Therapeutics Europe Ltd
Malaria
1 trial -
DEB025
ENANTA PHARMACEUTICALS INC
Hepatitis C Virus
1 trial -
DF-006-1001
Wuhan Createrna Science and Technology Co., Ltd
Chronic Hepatitis B
1 trial -
Debio 1453-101
Alphapharm Pty Ltd
Sexual Transmitted Infection (STI)
1 trial -
Defibrotide
Jazz Pharmaceuticals Ireland Limited
COVID
1 trial -
Disulfiram
BRIGHT MINDS BIOSCIENCES INC.
HIV Infections
1 trial -
Dronabinol Capsules
BRIGHT MINDS BIOSCIENCES INC.
HIV
1 trial -
EDP-235
ENANTA PHARMACEUTICALS INC
SARS CoV 2 Infection
1 trial -
EDP-297
ENANTA PHARMACEUTICALS INC
NASH - Nonalcoholic Steatohepatitis With Liver Fibrosis
1 trial -
EDP-305
ENANTA PHARMACEUTICALS INC
NASH - Nonalcoholic Steatohepatitis
2 trials -
EDP-322
ENANTA PHARMACEUTICALS INC
Skin and Soft Tissue Infections
1 trial -
EDP-323
ENANTA PHARMACEUTICALS INC
RSV Infection
3 trials -
EDP-494
ENANTA PHARMACEUTICALS INC
Hepatitis C
1 trial -
EDP-514
ENANTA PHARMACEUTICALS INC
Chronic HBV Infection
2 trials -
EDP-514
ENANTA PHARMACEUTICALS INC
Hepatitis B
1 trial -
EDP-721
ENANTA PHARMACEUTICALS INC
Chronic Hepatitis B Virus Infection
1 trial -
EDP239
ENANTA PHARMACEUTICALS INC
Hepatitis C
1 trial -
Electroporation-Mediated Plasmid DNA Vaccine Therapy
INOVIO PHARMACEUTICALS, INC.
Chronic Hepatitis
1 trial -
Emtricitabine
United Therapeutics Europe Ltd
HIV
1 trial -
Evaluation of the Novel Therapeutic Hepatitis... for chronic Hepatitis B
Disc Medicine
chronic Hepatitis B
1 trial -
Experimental Vaccine 1
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19 Pneumonia
1 trial -
Extracellular Vesicles from Mesenchymal Stem Cells
Regeneron Ireland Designated Activity Company (DAC)
COVID-19 Pneumonia
1 trial
Frequently asked questions
How many infectious disease pipeline programs are tracked?
1,112 programs match this therapeutic area based on indication text, program name, and registry metadata.
Where does pipeline data come from?
ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.